Taking the lead: Cellebrite DI Ltd (CLBT)

With 1.72 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.64 million shares. The 52-week range on CLBT shows that it touched its highest point at $26.30 and its lowest point at $10.24 during that stretch. It currently has a 1-year price target of $28.00. Beta for the stock currently stands at 1.46.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLBT was down-trending over the past week, with a drop of -18.76%, but this was down by -13.70% over a month. Three-month performance surged to 9.47% while six-month performance rose 19.59%. The stock gained 83.05% in the past year, while it has lost -10.76% so far this year. A look at the trailing 12-month EPS for CLBT yields -1.40 with Next year EPS estimates of 0.36. For the next quarter, that number is 0.05. This implies an EPS growth rate of 122.19% for this year and 19.29% for next year.

Float and Shares Shorts:

At present, 208.08 million CLBT shares are outstanding with a float of 76.82 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLBT since 6 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.23406 being high and -$1.35446 being low. For CLBT, this leads to a yearly average estimate of -$1.29426. Based on analyst estimates, the high estimate for the next quarter is $0.12 and the low estimate is $0.08. The average estimate for the next quarter is thus $0.1.